Twist Bioscience (TWST) Asset Writedowns and Impairment (2019 - 2024)
Twist Bioscience's (TWST) quarterly Asset Writedowns and Impairment came in at $293000.0 in Q3 2024, down 80.89% year-over-year from $1.5 million in Q4 2023, and up 103.47% quarter-over-quarter from $144000.0 in Q2 2024.
Analysis
Twist Bioscience (TWST) Asset Writedowns and Impairment (2019 - 2024) Analysis & Trends
Twist Bioscience (TWST) has reported Asset Writedowns and Impairment for 6 consecutive years, with $293000.0 the latest figure, recorded in Q3 2024.
- On a quarterly basis, Asset Writedowns and Impairment fell 80.89% year-over-year to $293000.0 in Q3 2024; TTM through Sep 2024 was $940000.0, a 63.47% decrease from a year earlier, with the FY2025 full-year figure at -$20000.0, down 102.13% from the prior year.
- Asset Writedowns and Impairment was $293000.0 for Q3 2024 at Twist Bioscience, up from $144000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $17.5 million in Q3 2022 and troughed at -$1.0 million in Q2 2020.
- A 5-year average of $1.3 million and a median of $293000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment jumped 1379.41% in 2022 and plunged 91.26% in 2023, its largest moves.
- Over 5 years, Asset Writedowns and Impairment stood at $248000.0 in 2020, then surged by 373.39% to $1.2 million in 2021, then plunged by 78.36% to $254000.0 in 2022, then declined by 2.36% to $248000.0 in 2023, then advanced by 18.15% to $293000.0 in 2024.
- The last three Asset Writedowns and Impairment figures came in at $293000.0 (Q3 2024), $144000.0 (Q2 2024), and $255000.0 (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Twist Bioscience | 8.93 Bn | 8.76 Bn | 62.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Mar 31, 2024 | 255,000.00 |
| Dec 31, 2023 | 248,000.00 |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 454,000.00 |
| Mar 31, 2023 | 332,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 17.53 Mn |
| Jun 30, 2022 | 985,000.00 |
| Mar 31, 2022 | 435,000.00 |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 830,000.00 |
| Mar 31, 2021 | -34,000.00 |
| Dec 31, 2020 | 248,000.00 |
| Sep 30, 2020 | 196,000.00 |
| Jun 30, 2020 | -1.01 Mn |
| Mar 31, 2020 | -463,000.00 |
| Dec 31, 2019 | 236,000.00 |